Clinical Trial Update: Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 clinical trial evaluating citicoline for treatment of newborns with hypoxic-ischemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Armed Forces Hospital, Pakistan | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 3 | Status: UNKNOWN